Document Detail

Citric acid as a decalcifying agent for the excised calcified human heart valves.
MedLine Citation:
PMID:  18400627     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Cardiac valvular pathologies are frequently encountered as mechanical and functional disorders due to the calcification of the valves whatever the etiologies are. This pathophysiologic table usually ends up with valvular replacement. In this study, we aimed to decrease/eliminate the calcium in the excised calcified human heart valves by using citric acid in vitro hence bringing about the question for possible oral treatment of calcification of the valves by citric acid ingestion. METHODS: Fourteen pieces of mitral and/or aortic valves excised from 12 patients undergoing valve replacement were placed in a freshly prepared phosphate buffered saline solution containing 0.625% glutaraldehyde at +4 0C for 48 h. They were rinsed with 0.9% NaCl and divided into two groups; study and control. Control tissues were further treated in a freshly prepared solution with identical properties for another 5 days. Study tissues were placed into a solution containing 3.8% citric acid (pH 7.4) and kept for 48 h at +37 degrees C, then rinsed with 0.9% NaCl and transferred into a fresh solution containing 0.625% glutaraldehyde with phosphate buffer at 37 0C for 3 more days. Specimens were biochemically and histopathologically evaluated and compared using Mann Whitney U test. RESULTS: Calcium and phosphate levels in the study group were lower than in the control group (852.5+/-913.41 microg g-1 vs 413.05+/-519.53 microg g-1, p=0.001 and 207.6+/-321.86 microg g-1 vs 124.4+/-289.48 microg g-1, p=0.035, respectively). Malondialdehyde and protein level values were changed insignificantly in the control and study groups. Histopathologic evaluation showed that collagen and elastin fibers were similar in both groups. In the study group, irregular and fusiform calcific formations around the collagen fibers were significantly decreased. CONCLUSIONS: Decalcifying human heart valves in vitro conditions with citric acid without an adverse change to the morphology of the valvular tissue specimens is meaningful. We believe that forwarding and looking for the answer to the question "whether systemic application of citric acid could lead to the decalcification and/or reduction of calcification in the native human heart valves" would be expressive.
Necmi Köse; Barlas Naim Aytaçoğlu; Necat Yilmaz; H Ali Döndaş; Lülüfer Tamer; Banu Coşkun; Ozden Vezir; Nehir Sucu; Murat Dikmengil
Related Documents :
1812017 - Aflatoxin in betel nut and its control by use of food preservatives.
16656357 - Sugars and organic acids of vitis vinifera.
21689207 - A simple test for the detection of kpc and metallo-β-lactamase carbapenemase-producing...
22062277 - Prediction of the fatty acid composition of beef by near infrared transmittance spectro...
17125217 - Trungapeptins a-c, cyclodepsipeptides from the marine cyanobacterium lyngbya majuscula.
18973997 - Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, d...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology     Volume:  8     ISSN:  1308-0032     ISO Abbreviation:  Anadolu Kardiyol Derg     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-04-10     Completed Date:  2008-06-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101095069     Medline TA:  Anadolu Kardiyol Derg     Country:  Turkey    
Other Details:
Languages:  eng     Pagination:  94-8     Citation Subset:  IM    
From Department of Cardiovascular Surgery, Faculty of Medicine, Mersin University, Mersin, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aortic Valve Stenosis / drug therapy,  pathology
Calcinosis / drug therapy,  pathology
Case-Control Studies
Chelating Agents / administration & dosage,  pharmacology*,  therapeutic use
Citric Acid / administration & dosage,  pharmacology*,  therapeutic use
Cross-Sectional Studies
Heart Valve Diseases / drug therapy,  pathology
Heart Valves / drug effects*,  pathology,  ultrastructure
Mitral Valve Stenosis / drug therapy,  pathology
Reg. No./Substance:
0/Chelating Agents; 77-92-9/Citric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nephrogenic systemic fibrosis associated with gadolinium use.
Next Document:  Statin use is associated with decreased CD-40 ligand expression on T lymphocytes of coronary atherom...